OUR VISION IS TO REDUCE ILLNESS AND DEATH ASSOCIATED WITH FUNGAL DISEASES WORLDWIDE.

News

Keep up to date with the latest news items from GAFFI.

Cryptococcal meningitis persists despite 90-90-90 – Botswana experience

Posted .

At the EMBO Mycoses in AIDS meeting in Cape Town, Dr Joe Jarvis working in Gabarone, Botswana questioned the value of 90-90-90 in reducing cryptococcal meningitis.   Just published in the prestigious journal Lancet HIV, is Botswana’s record in rolling our 90-90-90 antiretroviral therapy.  Botswana achieved: 83·3% individuals knew their HIV status, among these 87·4%, were… Read more »

Read more >

Importance of access to fungal disease diagnostics in AIDS highlighted in Russia by GAFFI’s President

Posted .

At the Russian-Chinese conference on Medical Microbiology and Clinical Mycology in St Petersburg, GAFFI’s President, Professor David Denning outlined the massive opportunity to save many lives from AIDS. In 2014, UNAIDS estimated that there were 1.2 million deaths from AIDS, ~400,000 attributable to TB. Four fungal infections probably account for over 500,000 deaths a year… Read more »

Read more >

Essential medicines in the USA – acquisition of generic marketing licenses causing exponential price rise

Posted .

In the USA an alarming trend for pharmaceutical companies to purchase marketing rights for aged off-patent drugs and then immediately raising the cost of the generic medication extortionately by as much as 5433% has been highlighted in an editorial in the New England Journal of Medicine (Alpern, Son & Stauffer, 2016). A much publicised case… Read more »

Read more >

Henk den Besten to join GAFFI as Senior Advisor

Posted .

Formerly Managing Director of IDA Foundation in the Netherlands, the world largest not for profit Essential Medicines Supplier, Henk is a pharmaceuticals supply chain expert.  His most recent role has been with the Partnership for Supply Chain Management which provides drug procurement for the President’s Emergency Plan for AIDS Relief (PEPFAR), focused on antiretroviral agents… Read more »

Read more >

Save the Children campaign: Every last child

Posted .

“Millions of children are denied the right to healthcare and an education because of who they are and where they live”. Today marks the launch event of the ‘Every Last Child’ campaign from Save the Children. The aim of the campaign is ensure that even the most marginalised and vulnerable children have what they need to… Read more »

Read more >

Burden of fungal diseases in Japan, Bangladesh, Malaysia, Peru and Congo presented at AAA7 and ECCMID        

Posted .

Major country differences in serious fungal diseases were found in the latest 5 countries to have their burden estimated – Japan (population 127M), Bangladesh (population 162M), Malaysia (population 30M) Peru (population 31M) and Congo (population 4.4M). These estimates were presented at the Advances Against Aspergillosis meeting in Manchester (March 3-5) and European Congress on Clinical… Read more »

Read more >

India State Minister announces free antifungal agents for the poor

Posted .

The Indian Health Minister, Kaul Singh Thakur has declared that the state government will provide free antifungal medicines to below poverty line patients. Speaking at the 11th National Conference of the Society of Indian Human and Animal Mycology at Kufri, the minister said the government was committed to include the common fungal diseases component in planning,… Read more »

Read more >

Open Letter on Disseminated histoplasmosis and AIDS – to key stakeholders tackling the AIDS epidemic

Posted .

The following open letter has been issued by GAFFI: To the World Health Organisation, UNAIDS, Pan-American Health Organisation, Médecins Sans Frontières, Bill and Melinda Gates Foundation, Drugs for Neglected Diseases Initiative, UNICEF, national public health agencies and governments. A recent rough estimate of disseminated histoplasmosis in AIDS is 100,000 cases worldwide and 80,000 deaths, mostly… Read more »

Read more >

GAFFI delivers its 2015 annual report

Posted .

GAFFI has progressed its mission to reduce illness and death associated with fungal diseases worldwide during 2014/15, its second year of operation. The disabling and stigmatising fungal tropical skin disease ‘Chromoblastomycosis’ has been added to GAFFI’s five priority diseases. GAFFI’s key activities have included: ‘95-95 by 2025’ 10 year Roadmap: GAFFI has drawn up a… Read more »

Read more >